Drug factory · FDA FEI 3003831171

Catalent Germany Schorndorf GmbH

Steinbeisstrasse 1-2, Schorndorf, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 17, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

7 drug inspections on record since 2009: 2 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
DabigatranPackages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0425, 0597-0430, 0597-0435 +3
Dutasteride and TamsulosinMakes it Waylis Therapeutics LLC 80725-809
Efbemalenograstim AlfaPackages it and labels it Acrotech Biopharma Inc 72893-016
ElinzanetantPackages it Bayer HealthCare Pharmaceuticals Inc. 50419-475
Lanthanum Cation (3+)Makes it, tests it, packages it and labels it Takeda Pharmaceuticals America, Inc. 54092-256, 54092-257

FDA inspection history

EndedResultProgramProblems noted
Mar 17, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 14, 2020Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 21, 2018Problems found, fixed voluntarilyDrug Quality Assurance1
Oct 26, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 7, 2014No problems foundDrug Quality Assurance—
Feb 10, 2012No problems foundDrug Quality Assurance—
Sep 3, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Sep 21, 2018 inspection

Registered with FDA for: analysis; label; manufacture; pack.